Home LiteratureArticle Details
PMID: 9528926 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen.

Endocrinology ·Vol. 139 ·No. 4 ·1998-04-00 ·Pages 1494-9

Huotari MA, Palgi J, Otonkoski T

Abstract

It is not clear which growth factors are crucial for the survival, proliferation, and differentiation of pancreatic beta-cells. We used the relatively differentiated rat insulinoma cell line INS-1 to elucidate this issue. Responsiveness of the DNA synthesis of serum-starved cells was studied to a wide variety of growth factors. The most potent stimulators were PRL, GH, and betacellulin, a member of the epidermal growth factor (EGF) family that has not previously been shown to be mitogenic for beta-cells. In addition to these, only vascular endothelial growth factor, insulin-like growth factor-1 and -2, had significant mitogenic activity, whereas hepatocyte growth factor, nerve growth factor-beta, platelet-derived growth factors, basic fibroblast growth factor, EGF, transforming growth factor-alpha (TGF-alpha), neu differentiation factor, and TGF-beta were inactive. None of these factors affected the insulin content of INS-1 cells. In contrast, certain differentiation factors, including nicotinamide, sodium butyrate, activin A, and 1,25-dihydroxyvitamin D3 inhibited the DNA synthesis and increased the insulin content. Also all-trans-retinoic acid had an inhibitory effect on cell DNA synthesis but no effect on insulin content. From these findings betacellulin emerges as a novel growth factor for the beta-cell. Half-maximal stimulation of INS-1 DNA synthesis was obtained with 25 pM betacellulin. Interestingly, betacellulin had no effect on RINm5F cells, whereas both EGF and TGF-alpha were slightly mitogenic. These effects may possibly be explained by differential expression of the erbB receptor tyrosine kinases. In RINm5F cells a spectrum of erbB gene expression was detected (EGF receptor/erbB-1, erbB-2/neu, and erbB-3), whereas INS-1 cells showed only expression of EGF receptor. Expression of the erbB-4 gene was undetectable in these cell lines. In summary, our results suggest that the INS-1 cell line is a suitable model for the study of beta-cell growth and differentiation because the responses to previously identified beta-cell mitogens were essentially similar to those reported in primary cells. In addition, we have identified betacellulin as a possible modulator of beta-cell growth.

MeSH Terms
Animals Betacellulin Cell Differentiation/drug effects Cell Division/drug effects Cell Line DNA/biosynthesis ErbB Receptors/genetics Gene Expression Growth Substances/pharmacology Human Growth Hormone/pharmacology Humans Insulin/biosynthesis Insulin-Like Growth Factor I/pharmacology Insulin-Like Growth Factor II/pharmacology Insulinoma Intercellular Signaling Peptides and Proteins Islets of Langerhans/cytology,drug effects Mitogens/pharmacology Pancreatic Neoplasms Prolactin/pharmacology Rats Recombinant Proteins/pharmacology
Chemicals
BTC protein, human Betacellulin Btc protein, rat Growth Substances Insulin Intercellular Signaling Peptides and Proteins Mitogens Recombinant Proteins Human Growth Hormone Insulin-Like Growth Factor I Insulin-Like Growth Factor II Prolactin DNA ErbB Receptors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Huotari M A
Transplantation Laboratory, Haartman Institute and Children's Hospital, University of Helsinki, Finland. [email protected]
Palgi J
Otonkoski T
Article Info
Journal
Endocrinology
Abbr.
Endocrinology
ISSN
0013-7227
Published
1998-04-00
Pages
1494-9
Language
English
Region
United States
NLM ID
0375040
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]